ANAGRELIDE for Neoplasm malignant: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 8 adverse event reports in the FDA FAERS database where ANAGRELIDE was used for Neoplasm malignant.
Most Reported Side Effects for ANAGRELIDE
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Headache | 86 | 6.4% | 10 | 22 |
| Anaemia | 78 | 5.8% | 11 | 31 |
| Palpitations | 72 | 5.4% | 7 | 17 |
| Platelet count increased | 61 | 4.6% | 1 | 16 |
| Dyspnoea | 60 | 4.5% | 3 | 34 |
| Cardiac failure | 56 | 4.2% | 12 | 35 |
| Cerebral infarction | 52 | 3.9% | 8 | 34 |
| Off label use | 49 | 3.7% | 3 | 32 |
| Fatigue | 46 | 3.4% | 1 | 9 |
| Drug ineffective | 44 | 3.3% | 0 | 7 |
| Diarrhoea | 41 | 3.1% | 10 | 11 |
| Myelofibrosis | 41 | 3.1% | 1 | 3 |
| Oedema peripheral | 40 | 3.0% | 2 | 27 |
| Renal impairment | 36 | 2.7% | 3 | 9 |
| Skin ulcer | 36 | 2.7% | 2 | 9 |
Other Indications for ANAGRELIDE
Essential thrombocythaemia (797)
Product used for unknown indication (273)
Thrombocytosis (75)
Myeloproliferative neoplasm (23)
Polycythaemia vera (23)
Platelet count increased (22)
Chronic myeloid leukaemia (15)
Janus kinase 2 mutation (13)
Thrombocytopenia (13)
Myelofibrosis (10)
Other Drugs Used for Neoplasm malignant
PALBOCICLIB (1,996)
CAPECITABINE (1,493)
PEMBROLIZUMAB (1,135)
PACLITAXEL (984)
CARBOPLATIN (977)
NIVOLUMAB (947)
OXALIPLATIN (823)
PAZOPANIB (716)
CYCLOPHOSPHAMIDE (685)
FLUOROURACIL (676)